Curing HIV and sickle cell falls short if the most vulnerable populations are left out
By Francis S Collins,
Fortune
| 03. 08. 2020
The year was 1984. I was finishing my medical genetics training at Yale, working on the molecular genetics of disorders of human hemoglobin. I was at a job interview at the University of Michigan when one of the senior professors asked what my lifetime goal was. "To contribute to scientific advances that would lead to a cure for sickle cell disease in Africa," I said. The professor laughed and said I was a hopeless dreamer.
That same year I saw my first case of HIV/AIDS. It was heartbreaking. This young man was wasting away in front of us, his body ravaged by infections that were taking advantage of his devastated immune system. There was little we could do, and he died in just a few weeks. I promised myself if there was ever a chance to help find a cure, I would do so.
Fast forward to today. The National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation (BMGF) have just embarked on a bold 10-year program to develop gene-based approaches to cure both sickle cell disease... see more
Related Articles
By Gabriela Arguedas-Ramírez, CRISPR Journal (paywall) | 04.21.2020
Abstract
I want to enrich the debate about the ethics and governance of human germline editing (HGE) by emphasizing an underappreciated, yet important, set of concerns regarding exclusionary practices, norms, and efforts that impede a broader discussion about the subject....
By Anon, Gulf Times [cites CGS' Katie Hasson] | 03.27.2020
The question of where the line should be drawn in human gene editing, and if it should be allowed to create ‘superhumans’, has been tackled by Doha Debates in the final debate of the Qatar Foundation production’s first season under...
Human Nature, a documentary about gene editing that had been due to open in many theaters in March, is suddenly available for streaming. The movie had its premiere in March 2019 at the South by Southwest Film Conference and Festival, followed by various showings around the world. Some (including one in San Francisco) were followed by panel discussions. The reviews are generally positive (95% on Rotten Tomatoes); being able to see it at home for four...
By CGS Staff
| 03.24.2020
During this time of social distancing, many people are off work, working from home, or skipping events and obligations that would otherwise be taking them out of the house. If these changes translate into time on your hands (and that’s certainly not the case for everyone!), we’ve assembled some of our favorite free resources so you can use this opportunity to brush up on the debates and conversations happening around human biotechnologies. We hope you’ll watch, learn, and share widely....
